WILMINGTON, Delaware, USA — DeNovix Inc. announces the award of US Patent 10,302,568 for their innovation in the field of cell counting. The CellDrop Automated Cell Counter, engineered with DirectPipette™ Technology, is the first image-based cell counter that completely eliminates the need for slides. The CellDrop Series features permanent sample surfaces that form a reusable […]
Existing Supply Agreement Remains Intact WALTHAM, Mass. and SARASOTA, Fla. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Roper Technologies (NYSE: ROP), a leading diversified technology company, today announced that they have mutually terminated the agreement under which Thermo Fisher would have acquired Gatan, Inc., a wholly owned subsidiary […]
USPTO issues sixth CRISPR-Cas9-related patent to University of California for genome editing and modulation of gene expression BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent (U.S. Patent No. 10,308,961) to University of California (UC) covering additional methods of using the CRISPR-Cas9 system. The unique methods form a toolset for both editing genes and […]
SAN JOSE, Calif. — Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware. The lawsuit alleges that a number of genetic sequencers and related reagents from Illumina, including the NovaSeq 6000, NextSeq series, and MiniSeq, are infringing Complete Genomics’ U.S. Patent No. 9,222,132 […]
USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]
USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]
SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group’s subsidiaries, BGI Europe A/S. Illumina filed suit in the Maritime & Commercial High Court of Denmark. “As we have previously stated, Illumina will continue to vigorously protect our patented technology and file patent suits where appropriate when our […]
US patent number 10,266,850 was previously involved in an interference proceeding DUBLIN, Ireland: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced today that the US Patent Office has issued US patent number 10,266,850 to Dr. Charpentier, together with The Regents of the […]
SAN DIEGO–(BUSINESS WIRE)–Mar. 29, 2019– Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group’s subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany. The complaint alleges that BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents, infringe EP 1 530 578 B1. This patent covers […]
Merck today announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects Marks company‘s 13th CRISPR patent overall Actively licensing CRISPR-related patents to interested parties Darmstadt, […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
